Focal Therapy For Prostate Cancer
Focal therapy, often referred to as a “male lumpectomy”, is a general term for a variety of noninvasive techniques for destroying small tumors inside the prostate while leaving the gland intact and sparing most of its normal tissue.
As technology advances, physicians have the ability to diagnose patients with prostate cancer earlier which means that tumors within the prostate may be small and contained to the prostate.
Advanced imaging techniques allow doctors to pinpoint exactly where in the prostate the tumor is located. By utilizing multi-parametric MRI and UroNav fusion biopsies, doctors are able to target the tumor within the prostate, leaving healthy tissue unharmed.
Focal therapy is studied all over the world due to its potential for reducing side effects, such as urinary incontinence and erectile dysfunction. Additionally, due to the noninvasive nature of focal therapy, treatment and recovery times are dramatically reduced.
- Reduced treatment time
- Faster recovery time
- Lower risk of incontinence
- Lower risk of erectile dysfunction
Focal Therapy with HIFU
Focal therapy with Sonablate HIFU technology creates a small, precise lesion. This targets the tumor within the prostate, leaving the surrounding tissue unharmed.
Experienced physicians use advanced software to merge MRI and real-time images of the prostate to locate the tumor and plan treatment to target that area only.
According to studies, focal therapy using HIFU in the treatment of non-metastatic prostate cancer has been shown to confer a low risk of genitourinary side-effects while encouraging early disease control.